Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.711
Abstract: Teriflunomide, a disease‐modifying treatment approved for multiple sclerosis (MS), inhibits reversibly dihydroorotate dehydrogenase, an enzyme involved in de novo pyrimidine biosynthesis and down‐regulates proliferation of activated lymphocytes. We aimed to study the impact of this… read more here.
Keywords: blood immune; tolerogenic bias; induces tolerogenic; immune cells ... See more keywords
Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2019.00157
Abstract: Dendritic cells (DC) are professional antigen presenting cells that have a key role in shaping the immune response. Tolerogenic DC (tolDC) have immuno-regulatory properties and they are a promising prospective therapy for multiple sclerosis and… read more here.
Keywords: pyruvate induces; ethyl pyruvate; dendritic cells; multiple sclerosis ... See more keywords
Corrigendum: The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.582491
Abstract: [This corrects the article DOI: 10.3389/fimmu.2018.01847.]. read more here.
Keywords: long noncoding; corrigendum long; noncoding rna; rna malat1 ... See more keywords